Funds and ETFs Medigen Biotechnology Corp.

Equities

3176

TW0003176004

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
38.7 TWD -0.64% Intraday chart for Medigen Biotechnology Corp. +1.84% -13.62%

ETFs positioned on Medigen Biotechnology Corp.

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +1.51% -
MEDIGEN BIOTECHNOLOGY CORP. is a Taiwan-based company principally engaged in the wholesales and distribution of general drugs. The Company is engaged in the licensing of technologies, the provision of technical services and testing services of nucleic acids. The Company's products and services include human leukocyte antigen (HLA) ABDR typing reagents, HLA typing and testing services, HLA SBT high-resolution typing reagents, HLA ABCDRDQ typing kits, nucleic acid testing reagents for the genotyping of human platelet, nucleic acid extraction instruments and reagents and blood screening specialized automated nucleic acid detection platforms. It also provides medical beauty care products. The Company distributes its products in Taiwan market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 3176 Stock
  4. Funds and ETFs Medigen Biotechnology Corp.